Background Our previous studies have investigated the role of hepatic insulin resistance (hepatic IR) and islet β-cell function in the pathogenesis of diabetes. This study aimed to explore the contributions of hepatic IR and islet β-cell dysfunction to the blood glucose spectrum in patients with newly diagnosed type 2 diabetes mellitus.
Methods Hepatic IR was assessed by the hepatic insulin resistance index (HIRI). Islet β-cell function was assessed by insulin secretion- sensitivity index-2 (ISSI2). The associations between blood glucose spectrum and hepatic IR and ISSI2 were analyzed.
Results A total of 707 patients with new-onset diabetes were included. The fasting blood glucose (FBG) and 30 minutes postload blood glucose elevated with rising HIRI (both P for trend <0.001). The FBG, 30 minutes, 2 hours, and 3 hours post-load blood glucose elevated with decreasing ISSI2 quartiles (all P for trend <0.001). There was a negative correlation between ISSI2 and HIRI after adjusting blood glucose levels (r=–0.199, P<0.001).
Conclusion Hepatic IR mainly contributed to FBG and early-phase postprandial plasma glucose, whereas β-cell dysfunction contributed to fasting and postprandial plasma glucose at each phase.
Citations
Citations to this article as recorded by
Interaction between insulin resistance and depression in predicting cardiovascular risk: Evidence from a longitudinal study Siyu Chen, Lijing Yang, Yu Zhou, Hao Yu Diabetes & Vascular Disease Research.2026;[Epub] CrossRef
Engineering the pancreatic niche: Mechanobiological insights into stem cell-derived β-cell therapy for diabetes mellitus Swaminadhan Dandapani, Yongsung Hwang Mechanobiology.2026;[Epub] CrossRef
Associations of adipose tissue insulin resistance with fasting blood glucose and HbA1c in adults without diabetes Ying Wei, Yong Tian, Ruixiang Cui, Ying Wang, Jia Liu, Guang Wang Diabetes, Obesity and Metabolism.2026;[Epub] CrossRef
Advancing in vitro vascular wall modelling using digital light processing to study hyperglycemia-driven cell changes Ianina Pokholenko, Marguerite Meeremans, Sandra Van Vlierberghe, Nele Pien, Catharina De Schauwer Frontiers in Bioengineering and Biotechnology.2026;[Epub] CrossRef
GLDC attenuates liver ischemia-reperfusion injury by inhibiting macrophage recruitment and activation via PTBP1/P2RY6 Zhitao Li, Li Jin, Yuan Fang, Siming Qu, Bo Yuan, Kai Gan, Hanfei Huang Cellular Signalling.2025; 135: 111976. CrossRef
The Physiological and Pathological Mechanisms of LIN2, LIN7, LIN10 and Their Tripartite Complex Yangyang Shang, Xinyi Gan, Yue Dang, Jie Liu, Peijun Liu Journal of Cellular and Molecular Medicine.2025;[Epub] CrossRef
Cinnamic Acid: A Shield Against High-Fat-Diet-Induced Liver Injury—Exploring Nrf2’s Protective Mechanisms Asmahan Taher Alahdal, Laila Naif Al-Harbi, Ghedeir M. Alshammari, Ali Saleh, Mohammed Abdo Yahya International Journal of Molecular Sciences.2025; 26(16): 7940. CrossRef
Sodium Butyrate Ameliorated Bile Acid Metabolism in Diabetes Mellitus by PI3K/AKT Signaling Pathway via the Gut–Liver Axis Tingting Zhao, Xi Zhang, Qian Xiang, Yadi Liu, Xuling Li, Junling Gu, Wenqian Zhang, Zhe Wang, Yiran Li, Xiaoshan Lai, Yonghua Zhao, Youhua Xu Current Issues in Molecular Biology.2025; 47(9): 732. CrossRef
Expanding horizons: the role of robotic surgery in modern transplantation practices Arya Afrooghe, Pedram Pirmoradian, Moein Ghasemi, Benyamin Mohammadi, Mahya Soleymani Mehranjani, Elham Ahmadi, Seyed Amir Miratashi Yazdi Journal of Robotic Surgery.2025;[Epub] CrossRef
Elevated PEDF promotes the occurrence of diabetes mellitus via suppressing GSIS by downregulating the SNARE complex Zhen Zhao, Yandan Tan, Jie Fang, Gan Xia, Junchen Li, Qilong Tang, Wanting Xie, Tianxiao Gao, Zhenzhen Fang, Ti Zhou, Xia Yang, Guoquan Gao, Weiwei Qi Communications Biology.2025;[Epub] CrossRef
Distinct Circulating Biomarker Profiles Associated with Type 2 Diabetes in a Regional Cohort—A Cross-Sectional Study Abdullah Alsrhani, Muhammad Atif, Aisha Farhana Metabolites.2025; 15(12): 776. CrossRef
Application and Predictive Potential of Novel Insulin Resistance Assessment Indices in Metabolic Diseases 莹莹 郑 Advances in Clinical Medicine.2025; 15(12): 2174. CrossRef